Dr. David Sendrowski, OD

NPI: 1255349262
Total Payments
$3,274
2024 Payments
$23.09
Companies
9
Transactions
14
Medicare Patients
89
Medicare Billing
$5,342

Payment Breakdown by Category

Other$2,048 (62.5%)
Consulting$800.00 (24.4%)
Food & Beverage$426.56 (13.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $2,048 1 62.5%
Consulting Fee $800.00 1 24.4%
Food and Beverage $426.56 12 13.0%

Top Paying Companies

Company Total Records Latest Year
OPTOVUE, INC. $2,165 3 $0 (2019)
Allergan, Inc. $857.03 3 $0 (2021)
Oyster Point Pharma, Inc. $68.76 1 $0 (2022)
AbbVie Inc. $53.11 2 $0 (2023)
Bausch & Lomb, a division of Bausch Health US, LLC $34.85 1 $0 (2018)
Glaukos Corporation $25.54 1 $0 (2021)
Bausch & Lomb Americas Inc. $23.99 1 $0 (2023)
Alcon Vision LLC $23.09 1 $0 (2024)
Novartis Pharmaceuticals Corporation $23.09 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $23.09 1 Alcon Vision LLC ($23.09)
2023 $58.99 2 AbbVie Inc. ($35.00)
2022 $86.87 2 Oyster Point Pharma, Inc. ($68.76)
2021 $855.52 3 Allergan, Inc. ($829.98)
2019 $71.40 1 OPTOVUE, INC. ($71.40)
2018 $2,151 4 OPTOVUE, INC. ($2,093)
2017 $27.05 1 Allergan Inc. ($27.05)

All Payment Transactions

14 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
05/04/2024 Alcon Vision LLC Rocklatan (Drug) Food and Beverage In-kind items and services $23.09 General
Category: Ophthalmology
11/17/2023 Bausch & Lomb Americas Inc. MIEBO (Drug) Food and Beverage In-kind items and services $23.99 General
Category: Ophthalmology
06/22/2023 AbbVie Inc. DURYSTA (Drug) Food and Beverage In-kind items and services $35.00 General
Category: EYE CARE
09/12/2022 Oyster Point Pharma, Inc. TYRVAYA (Drug) Food and Beverage In-kind items and services $68.76 General
Category: DRY EYE
09/09/2022 ABBVIE INC. VUITY (Drug) Food and Beverage In-kind items and services $18.11 General
Category: OPHTHALMOLOGY
12/08/2021 Glaukos Corporation KXL System (Device), Photrexa Food and Beverage In-kind items and services $25.54 General
Category: Keratoconus
06/15/2021 Allergan, Inc. DURYSTA (Drug), LUMIGAN, XEN GLAUCOMA TREATMENT SYSTEM Consulting Fee Cash or cash equivalent $800.00 General
Category: GLAUCOMA
06/15/2021 Allergan, Inc. DURYSTA (Drug), LUMIGAN, XEN GLAUCOMA TREATMENT SYSTEM Food and Beverage In-kind items and services $29.98 General
Category: GLAUCOMA
11/16/2019 OPTOVUE, INC. XR (Device) Food and Beverage Cash or cash equivalent $71.40 General
Category: Optometry
11/30/2018 Novartis Pharmaceuticals Corporation TRAVATAN Z (Drug) Food and Beverage In-kind items and services $23.09 General
Category: OPHTHALMOLOGY
06/15/2018 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Food and Beverage In-kind items and services $34.85 General
Category: OPHTHALMOLOGY
04/09/2018 OPTOVUE, INC. AngioVue (Device) Honoraria Cash or cash equivalent $2,047.66 General
Category: Optometrist
01/05/2018 OPTOVUE, INC. XR (Device) Food and Beverage Cash or cash equivalent $45.70 General
Category: Optometrist
09/18/2017 Allergan Inc. LUMIGAN (Drug) Food and Beverage In-kind items and services $27.05 General
Category: OPHTHALMOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 23 36 $3,660 $1,905
2022 4 55 69 $6,110 $2,796
2020 1 11 11 $1,320 $641.41
Total Patients
89
Total Services
116
Medicare Billing
$5,342
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 12 24 $2,880 $1,575 54.7%
92133 Imaging of optic nerve Office 2023 11 12 $780.00 $329.68 42.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 18 25 $3,000 $1,564 52.1%
92083 Exam of visual field with extended testing Office 2022 12 15 $1,500 $660.24 44.0%
92133 Imaging of optic nerve Office 2022 14 18 $1,170 $461.07 39.4%
92202 Extended exam of the back part of the eye with optic nerve drawing Office 2022 11 11 $440.00 $110.12 25.0%
92083 Measurement of field of vision during daylight conditions Office 2020 11 11 $1,320 $641.41 48.6%

About Dr. David Sendrowski, OD

Dr. David Sendrowski, OD is a Optometrist healthcare provider based in Fullerton, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255349262.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Sendrowski, OD has received a total of $3,274 in payments from pharmaceutical and medical device companies, with $23.09 received in 2024. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Honoraria" ($2,048).

As a Medicare-enrolled provider, Sendrowski has provided services to 89 Medicare beneficiaries, totaling 116 services with total Medicare billing of $5,342. Data is available for 3 years (2020–2023), covering 7 distinct procedure/service records.

Practice Information

  • Specialty Optometrist
  • Location Fullerton, CA
  • Active Since 08/04/2006
  • Last Updated 02/17/2010
  • Taxonomy Code 152W00000X
  • Entity Type Individual
  • NPI Number 1255349262

Products in Payments

  • AngioVue (Device) $2,048
  • DURYSTA (Drug) $864.98
  • XR (Device) $117.10
  • TYRVAYA (Drug) $68.76
  • VYZULTA (Drug) $34.85
  • LUMIGAN (Drug) $27.05
  • KXL System (Device) $25.54
  • MIEBO (Drug) $23.99
  • Rocklatan (Drug) $23.09
  • TRAVATAN Z (Drug) $23.09
  • VUITY (Drug) $18.11

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Optometrist Doctors in Fullerton